Nuformix (LSE:NFX) Total Long-Term Assets : £0.90 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Nuformix's Total Long-Term Assets for the quarter that ended in Mar. 2025 was £0.90 Mil.

Nuformix Total Long-Term Assets Historical Data

The historical data trend for Nuformix's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Total Long-Term Assets Chart

Nuformix Annual Data

Trend

Dec15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sep24

Total Long-Term Assets

Get a 7-Day Free Trial

4.33

4.19

4.15

4.11

0.91

Nuformix Semi-Annual Data
	Dec15	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24	Sep24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial													4.13	4.11	4.07	0.91	0.90

Nuformix Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Nuformix Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Nuformix's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.